Best Monoamine Oxidase Inhibitor for parkinson disease
Top-rated pick: Azilect — pharmaranks score 56/100, the highest of the 3 Monoamine Oxidase Inhibitor drugs used for parkinson disease, ranked by our independent FDA recall-safety score. Compare them with all treatments for parkinson disease or the full Monoamine Oxidase Inhibitor class. Not medical advice — always consult a professional.
Quick answer: Of the 3 monoamine oxidase inhibitor drugs we rate for parkinson disease, all are available as lower-cost generics, and most are tablet. Our ranking reflects each drug’s FDA recall-safety record — not clinical effectiveness for parkinson disease; the right choice depends on your situation, so confirm it with your prescriber.
Other drug classes for parkinson disease
Top monoamine oxidase inhibitor for parkinson disease: 1. Azilect · 2. Emsam · 3. Zelapar
| # | Drug | Rating | Type | Form | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|
| 1 | 56/100 | Prescription | Tablet | Generic | $30 | View → | |
| 2 | Not yet rated | Prescription | Patch | Generic | $20 | View → | |
| 3 | Not yet rated | Prescription | Tablet | Generic | $20 | View → |
Full ranking · 3 drugs
azilect
PrescriptionFDA-sourced
Azilect (Rasagiline Mesylate) is a monoamine oxidase inhibitor used to treat Parkinson Disease.
Pharmacy pays
From ~$28.05/30· 2 forms Save up to 42% in classemsam
PrescriptionFDA-sourced
Emsam (Selegiline) is a monoamine oxidase inhibitor used to treat Alzheimer Disease, Attention Deficit Disorder with Hyperactivity, Depressive Disorder, Parkinson Disease.
Pharmacy pays
From ~$19.44/30· 2 forms Save up to 10% in classzelapar
PrescriptionFDA-sourced
Zelapar (Selegiline Hydrochloride) is a monoamine oxidase inhibitor used to treat Alzheimer Disease, Attention Deficit Disorder with Hyperactivity, Depressive Disorder, Parkinson Disease.
Pharmacy pays
From ~$19.44/30· 2 forms Save up to 10% in classFrequently asked
- What is the best monoamine oxidase inhibitor for parkinson disease?
- By our independent recall-safety rating — not an efficacy measure — azilect ranks highest among Monoamine Oxidase Inhibitor drugs used for parkinson disease. Always consult a professional.
- Which monoamine oxidase inhibitor drugs treat parkinson disease?
- pharmaranks lists 3 Monoamine Oxidase Inhibitor products used for parkinson disease, per NIH RxClass drug-classification data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.